Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
Cenovis Glucosamine 1500 (Sanofi-Aventis Healthcare Pty Ltd T/A Sanofi Consumer Healthcare)
Product Name
Cenovis Glucosamine 1500
ARTG
233934
Date of review outcome
Date of publication
Dec-20
Outcome
Medicine continues to be permitted for supply
Is it safe to continue using this medicine?
Yes
What action should consumers take?
Be aware that the tablet may not be as breakable as claimed on the label
Review scope
Targeted
Information reviewed
Labels, Manufacturing Documentation, Sample
Issues related to safety
None
Issues related to efficacy
The efficacy of the medicine was not assessed as part of this review
Actions taken during the review
The TGA required the sponsor to correct the minor issues with the medicine. The sponsor will no longer be supplying the medicine with the current label.